U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H21ClN6O3
Molecular Weight 464.904
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of LOPRAZOLAM

SMILES

CN1CCN(CC1)\C=C2/N=C3CN=C(C4=CC=CC=C4Cl)C5=C(C=CC(=C5)[N+]([O-])=O)N3C2=O

InChI

InChIKey=UTEFBSAVJNEPTR-RGEXLXHISA-N
InChI=1S/C23H21ClN6O3/c1-27-8-10-28(11-9-27)14-19-23(31)29-20-7-6-15(30(32)33)12-17(20)22(25-13-21(29)26-19)16-4-2-3-5-18(16)24/h2-7,12,14H,8-11,13H2,1H3/b19-14-

HIDE SMILES / InChI
Molecular Formula C23H21ClN6O3
Molecular Weight 464.904
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description
Sources: www.mhra.gov.uk/home/groups/par/documents/websiteresources/con418469.pdf
Curator's Comment: description was created based on several sources, including, http://home.intekom.com/pharm/hmr/dormnoct.html

Loprazolam is a hypnotic drug which stimulates GABA-A receptors. Due to its hypnotic activity the drug is used to treat short-term sleep disordes.

CNS Activity

CNS Active
3913
Curator's Comment: The drug is hypnotic.

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
GABA-A receptor; benzodiazepine site
38
Target ID: CHEMBL2109243
Sources: www.mhra.gov.uk/home/groups/par/documents/websiteresources/con418469.pdf
Agonist
2678
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
DORMONOCT

Approved Use

Short-term treatment of insomnia.Sleep disturbances in the geriatric patient. Pre-operative sleep disturbances.
PubMed

PubMed

TitleDatePubMed
Patents

Patents

US4044142 A
3

Sample Use Guides

In Vivo Use Guide
The usual adult dose is 1 - 2 mg at bedtime.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:46:09 GMT 2023
Edited
by admin
on Fri Dec 15 15:46:09 GMT 2023
Record UNII
759N8462G8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LOPRAZOLAM
INN   MI   WHO-DD  
INN  
Official Name English
loprazolam [INN]
Common Name English
(Z)-6-(O-CHLOROPHENYL)-2,4-DIHYDRO-2-((4-METHYL-1-PIPERAZINYL)METHYLENE)-8-NITRO-1H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-1-ONE
Common Name English
(2Z)-6-(2-CHLOROPHENYL)-2,4-DIHYDRO-2-((4-METHYL-1-PIPERAZINYL)METHYLENE)-8-NITRO-1H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-1-ONE
Systematic Name English
TRIAZULENONE, (Z)-
Common Name English
1H-IMIDAZO(1,2-A)(1,4)BENZODIAZEPIN-1-ONE, 6-(2-CHLOROPHENYL)-2,4-DIHYDRO-2-((4-METHYL-1-PIPERAZINYL)METHYLENE)-8-NITRO-, (2Z)-
Systematic Name English
RU-31158 FREE BASE
Code English
LOPRAZOLAM [MI]
Common Name English
TRIAZULENONE, (Z)-ISOMER
Common Name English
TRIAZULENONE
Common Name English
Loprazolam [WHO-DD]
Common Name English
Classification Tree Code System Code
DEA NO. 2773
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
WHO-VATC QN05CD11
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
NCI_THESAURUS C1012
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
WHO-ATC N05CD11
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
Code System Code Type Description
FDA UNII
759N8462G8
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
EPA CompTox
DTXSID30894873
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
NCI_THESAURUS
C66032
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
PUBCHEM
3033860
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
INN
4884
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
MERCK INDEX
m6901
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY Merck Index
DRUG CENTRAL
1602
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
RXCUI
38555
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY RxNorm
CAS
61197-73-7
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
EVMPD
SUB08576MIG
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
SMS_ID
100000082009
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
WIKIPEDIA
LOPRAZOLAM
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
DRUG BANK
DB13643
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
MESH
C020168
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107448
Created by admin on Fri Dec 15 15:46:09 GMT 2023 , Edited by admin on Fri Dec 15 15:46:09 GMT 2023
PRIMARY
Related Record Type Details
Structure of LOPRAZOLAM MESILATE
SALT/SOLVATE -> PARENT
Related Record Type Details
Structure of LOPRAZOLAM
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966